Rimegepant (Nurtec ODT) for Acute Treatment of Migraine

This Medical Letter review summarizes evidence supporting the use of rimegepant (Nurtec), a small-molecule calcitonin gene-related peptide receptor antagonist, for acute treatment of migraine with or without aura in adults.
Source: JAMA - Category: General Medicine Source Type: research